Charles River Laboratories International Inc. logo

Charles River Laboratories International Inc.

CRL | NYSE
Chart Builder DCF Calculator
$287.31
+$8.30 (+2.97%)
Sep 22, 2026, 11:21 AM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 26, 2025
FY 2024
Dec 27, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Net Income
-142.16M 25.29M 480.37M 492.61M 398.84M 365.31M
Depreciation & Amortization
403.31M 361.74M 314.12M 303.87M 265.54M 234.92M
Stock-Based Compensation
71.08M 69.89M 72.05M 73.62M 71.47M 56.34M
Other Working Capital
24.25M -54.47M 13.78M 79.19M 49.83M 76.98M
Other Non-Cash Items
466.63M 375.41M -29.36M -62.02M 6.01M -83.59M
Deferred Income Tax
-75.29M -67.43M -50.9M -35.88M -24.01M -133K
Change in Working Capital
14.08M -30.33M -102.38M -152.55M 42.94M -26.28M
Operating Cash Flow
737.65M 734.58M 683.9M 619.64M 760.8M 546.58M
Capital Expenditures
-219.15M -232.97M -318.53M -324.73M -228.77M -166.56M
Cash Acquisitions
17.44M -5.48M -194.79M -120.12M -1.17B -418.63M
Purchase of Investments
-20.08M -52.88M -54.22M -158.27M -45.56M -26.69M
Sales Maturities Of Investments
9.1M 41.69M 6.67M 4.55M 6.53M 11.4M
Other Investing Acitivies
3.36M 4.55M -2.29M -9.35M 264K -1.07M
Investing Cash Flow
-209.32M -245.09M -563.16M -607.92M -1.44B -601.54M
Debt Repayment
-121.78M -412.19M -75.32M 19.79M 669.98M 30.59M
Common Stock Repurchased
-360.67M -119.18M -24.16M -38.65M -40.71M -23.98M
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-54.98M -19.56M 13.96M -23.54M 43.32M 40.64M
Financial Cash Flow
-536.73M -550.93M -85.52M -42.4M 672.6M 47.25M
Net Cash Flow
10.43M -78.91M 43.27M -5.1M 13.2M -6.93M
Free Cash Flow
518.49M 501.61M 365.37M 294.91M 532.03M 380.02M
Adj. Free Cash Flow
447.41M 431.72M 293.32M 221.29M 460.55M 323.67M
Maintenance CapEx
-219.15M -232.97M -248.91M -130.68M n/a -30.19M
Growth CapEx
n/a n/a -69.62M -194.05M -228.77M -136.37M
Owner Earnings
518.49M 501.61M 434.99M 488.96M 760.8M 516.39M

© 2026 bestshares.com. All rights reserved.